The DV Platform™ Accelerating Drug Development
SciMar One, Inc
The DV Platform™ Accelerating Drug Development
SciMar One, Inc
The DV Platform™ Accelerating Drug Development
SciMar One, Inc
Accelerate drug development with Azure AI for R&D savings
The DV Platform™ is a Microsoft Azure-powered platform enabling pharma teams to find and operationalize clinical data to accelerate drug development. The DV Platform's™ advanced search features and pharma-specific project management tools accelerate innovation in drug development by shifting the time-consuming tasks of clinical data analytics from humans to technology. The DV Platform™ replaces outdated manual processes to dramatically reduce costs, time, and risks of moving drugs from Phase 2 to commercialization, saving lives and improving patient outcomes.
KEY BENEFITS
Advancing a drug from Phase 2 to commercialization takes 5-7 years and requires completion of >300 critical tasks by 12 cross-functional drug development teams. In one platform, the DV Platform™ orchestrates cross-functional collaboration and task completion bringing new therapies to market up to five working years faster than current manual methods. The DV Platform™:
- Informs drug development tasks with relevant disease-specific clinical data
- Coordinates cross-functional drug development tasks across an organization
- Evolves stagnant business models
FIND DATA FASTER WITH ADVANCED SEARCH:
- AI-based search tools find relevant clinical data faster than manual methods and eliminate irrelevant data from review
- Consistently saves users 96% of analytical time and reduces data analytics costs by 50% over a 5-year development program
- Provides full value of clinical data to extend product lifecycle
- Accelerates task completion
OPERATIONALIZE DATA WITH PHARMA-SPECIFIC PROJECT MANAGEMENT TOOLS:
- The DV Platform™ coordinates hundreds of tasks required to advance a drug from Phase 2 to commercialization and beyond
- Drug development teams gain efficiencies by collaborating in one central system
- Secure valuable IP, data, and work history in the DV Platform™. Mitigate losses due to staff turnover
- The DV Platform™ typically drives cost savings of 2% - 4% of annual R&D spend
KEY FEATURES
FOR USERS:
- Simple navigation and visualization to quickly find, share, and archive data. Easily collaborate to accelerate workflow.
By leveraging the power of Azure, the DV Platform™ helps your team become a better-informed and more-collaborative community for developing drugs that can improve patients’ lives.
- The DV Platform™ and Machine Learning: Saves time and reduces costs by standardizing exclusions to keep irrelevant material out of the analysis process
- The DV Platform™ and Natural Language Processing: Automates and accelerates metadata tagging to focus analysis on the disease-specific data model
- The DV Platform™ and Azure AI: AI model learns client preferences autonomously in real-time to align relevant data to the task at hand
THE SDE + THE POWER OF AZURE = LIVES SAVED
SciMar ONE offers Better Healthcare Through Data with AI technologies that accelerate pharmaceutical drug development. The DV Platform™ was developed by scientists with deep knowledge of pharmaceutical drug development.